Literature DB >> 26123322

Zileuton for Pruritus in Sjögren-Larsson Syndrome: A Randomized Double-blind Placebo-controlled Crossover Trial.

Joris Fuijkschot1, Marieke M B Seyger, Diane E T Bastiaans, Ron A Wevers, Nel Roeleveld, Michèl A A P Willemsen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26123322     DOI： 10.2340/00015555-2195

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN： 0001-5555            Impact factor:   4.437


× No keyword cloud information.
  4 in total

1.  Genetics and prospective therapeutic targets for Sjögren-Larsson Syndrome.

Authors:  William B Rizzo
Journal:  Expert Opin Orphan Drugs       Date:  2016-03-10       Impact factor: 0.694

2.  Atypical Presentation of Sjögren-Larsson Syndrome.

Authors:  D Papathemeli; A Mataftsi; A Patsatsi; D Sotiriadis; M Samouilidou; S Chondromatidou; A Evangeliou
Journal:  Case Rep Pediatr       Date:  2017-10-18

Review 3.  Sjogren-Larsson Syndrome: Mechanisms and Management.

Authors:  Parayil Sankaran Bindu
Journal:  Appl Clin Genet       Date:  2020-01-07

4.  Leukotriene Antagonists in Dermatology.

Authors:  Aditya Kumar Bubna
Journal:  Indian J Dermatol       Date:  2021 Sep-Oct       Impact factor: 1.494
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.